{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoNSTy44KDA","lastupdate":"2023-11-03T00:00:00.000Z","update_date":"2023-11-03T00:00:00.000Z","lastModified":"Mar 25, 2024","active":1,"confidence_score":99,"confidence_score_reason":"markets","urlname":"corneat-vision","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$QWmqvmWtjlXJI2bOLj0Dwbv4I8DSwA4y8bsd1g408JmVcyd0XIxoR1","name":"CorNeat Vision","oneliner":"A new era of medical devices","registrar":"515356293","website":"https://www.corneat.com/","careerspage":"","founded_month":12,"founded_year":2015,"formernames":[],"sociallinks":{"twitter":"","youtube":"https://www.youtube.com/channel/UCo1Ma47GaQ5zecSC98a9vbw","facebook":"","linkedin":"https://www.linkedin.com/company/18006267","instagram":""},"social":["https://www.youtube.com/channel/UCo1Ma47GaQ5zecSC98a9vbw","https://www.linkedin.com/company/18006267"],"flattenedsociallinks":"https://www.youtube.com/channel/UCo1Ma47GaQ5zecSC98a9vbw|https://www.linkedin.com/company/18006267","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":20,"patent":1,"raised":18765000,"stage":"B","public_stage":"B","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["corneat","Corneat","Cor Neat Vision","Cor-neat Vision"],"about":"CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger.\n\nThe EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants.\n\nThe EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"","country":null,"address":{"israeli":[{"id":"a9410f0e-e916-4f9e-b026-5e67580b2276","city":"Ra'anana","type":null,"address":"4 HaSheizaf Street, Ra'anana, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"GxvqOKhe2WwfxInjSdmtaJaf8ivhuTDnUwv4NGF1ey0Db2XogP6jSr","date":"Sep 2, 2025","link":"https://www.prnewswire.com/il/news-releases/corneat-visions-artificial-cornea-restores-perfect-2020-vision-in-shingles-blinded-eye-302543974.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"clinical trial","round":null,"company":"CorNeat Vision","layoffs":null,"summary":"CorNeat Vision, an ophthalmic medical device company, has achieved a significant milestone in its RESEE clinical trial, reaching 50% enrollment. The trial focuses on the CorNeat KPro, an artificial cornea that has successfully restored perfect vision in a patient blinded by corneal scarring from Shingles. This achievement is notable as the patient was not a candidate for traditional corneal transplantation. The CorNeat KPro integrates with the eye wall, eliminating the need for donor tissue and providing long-term stability. The trial aims for FDA 510(k) clearance and CE Marking, with expansion plans to include US clinical centers by 2026. The project is supported by the European Innovation Council and a U.S. Army Project Award.","partners":null,"customers":null,"eventType":null,"investors":["European Innovation Council","U.S. Army Project Award"],"confidence":9,"key_topics":["clinical trial","artificial cornea","vision restoration","FDA clearance","synthetic implant"],"date_of_event":"September 12, 2023","product_stage":"clinical trial","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","FDA approved/pending approval"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Product Stage  #FDA approved/pending approval","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wcLi12IuremwOVs9RHzCUJexJGARoSqAQw5VEIoAk1Z2kPF8kt5esA","news_summary":"/PRNewswire/ -- CorNeat Vision, an innovative ophthalmic medical device company, has announced a groundbreaking clinical achievement: the restoration of...","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"bVoHAGb2UWhXSTcvK0bjm9LGQKvA3WPBH9qoQ1yYR1rJ7OqNU5EN56","date":"Jun 10, 2023","link":"https://nocamels.com/2023/06/fda-okays-worlds-first-non-degradable-synthetic-eye-tissue/","source":"nocamels.com","visible":1,"analysis":{"tags":"FDA approval, synthetic tissue substitute","company":"CorNeat Vision","layoffs":"NA","summary":"The American Food & Drug Administration (FDA) has approved an Israeli-made synthetic tissue substitute for the eye developed by Israeli startup CorNeat Vision. The product, EverPatch, is the world’s first non-degradable synthetic tissue for ophthalmic surgery. It is made of a polymer that stimulates the cells to accept it and incorporate it into the eye tissue. The EverPatch was designed to replace the use of donor tissue, which poses the risk of disease transmission. It will be launched initially in the leading ophthalmic centers in the US in the coming months, and expand nationwide later in the year.","partners":"NA","customers":"ophthalmic centers in the US","investors":"NA","confidence":9,"key_topics":["FDA approval","synthetic tissue","ophthalmic surgery","EverPatch","EverMatrix"],"date_of_event":"NA","valuation_amount":"NA","impact_on_company":"growth-positive","investment_amount":"NA","structured_issues":["Customers","Expand"],"acquisition_amount":"NA","structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"BoypnWJ01DSDkQumCQ37T9siQF7jWJougauz9JFA3alTaRGyAuZbbP","news_summary":"FDA Approves Israeli Non-Degradable Synthetic Eye Tissue","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ea6d77b5-42d2-40fa-af13-a132d59490e9","date":"Aug 25, 2021","link":"https://www.calcalistech.com/ctech/articles/0,7340,L-3916036,00.html","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Investment, Expansion","company":"CorNeat Vision","layoffs":"Not mentioned","summary":"Israel-based medtech startup, CorNeat Vision, has raised $4 million from the Guangzhou Sino-Israel Biotech Investment Fund (GIBF). The funds will be invested in CorNeats Chinese subsidiary in Guangzhou, with the aim to expand the companys activities in the Chinese market. This includes conducting clinical trials, setting up a manufacturing facility, and marketing the companys first two products. CorNeat Vision, founded in 2015, develops a synthetic cornea that operates by inserting artificial optics under the membrane that covers the white of the eyes.","partners":"Not mentioned","customers":"Not mentioned","investors":"Guangzhou Sino-Israel Biotech Investment Fund (GIBF)","confidence":9,"key_topics":["Medtech","Synthetic Cornea","Investment","Chinese Market","Clinical Trials"],"date_of_event":"25.08.21","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$4 million","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xFqCKS96lZhkjOX4QbHxgAfoddEyhxG099KbrstufCsAOptdKwJMYA","news_summary":"CorNeat Vision raises $4 million from Israeli-Chinese GIBF fund","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"62d6b6dc-4490-4432-bd71-bfe24b698c4d","date":"Feb 4, 2021","link":"https://www.jpost.com/opinion/hillels-tech-corner-corneat-vision-helping-blind-people-see-again-657891","source":"www.jpost.com","visible":1,"analysis":{"tags":"Medical Technology","company":"CorNeat Vision","layoffs":"Not mentioned","summary":"CorNeat Vision, an Israeli company, has developed a technology that has helped a blind man see again. The company was founded in 2015 and focuses on clinical-stage, biomimetic implant technology. They have invented an artificial cornea and a synthetic non-degradable patch that are currently in clinical trials. They have also developed a glaucoma drainage device and a product for gingival recession that are in advanced animal testing. The company has raised over $12 million from private investors and a Swiss hedge fund. They plan to continue investing in low-medium income countries and offer their solutions there.","partners":"Not mentioned","customers":"Not mentioned","investors":["Private investors","Swiss hedge fund"],"confidence":9,"key_topics":["Artificial Cornea","Clinical Trials","Investment","Global Recognition","Expansion"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$12 million","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"75g2VAIP8nbS0Yb4zW1iPFClFW02t8m7Sati1DjdU7AGOpSEOXMido","news_summary":"https://www.jpost.com/opinion/hillels-tech-corner-corneat-vision-helping-blind-people-see-again-657891","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7ea4aeb3-d7db-4b51-946a-07490b351f4d","date":"Jan 18, 2021","link":"https://www.israel21c.org/jamal-can-see-again-thanks-to-new-synthetic-cornea/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"Medical Innovation","company":"CorNeat Vision","layoffs":"N/A","summary":"CorNeat Vision, a company based in Raanana, has successfully implanted its KPro artificial cornea into a patient, restoring his vision. The patient, Jamal Furani, had lost his vision due to corneal disease and previous donor transplants had failed. The successful surgery took place on January 3rd. CorNeat Visions cofounder, CEO & VP R&D, Almog Aley-Raz, stated that this is the first step in a multinational clinical trial, with the aim of attaining CE Mark, FDA clearance and China NMPA approval. The company plans to initiate a second study later this year.","partners":["Beilinson Hospital of Rabin Medical Center","Rabin Medical Center"],"customers":["Jamal Furani"],"investors":"N/A","confidence":9,"key_topics":["Artificial Cornea","Clinical Trial","Vision Restoration","Medical Innovation","Patient Success"],"date_of_event":"January 3","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Customers","Partners"],"acquisition_amount":"N/A","structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6suwwhPq1PJLYKkF6sMtsD7jxJWTVU4GEGBfcOLcVvp8Pmx3ybYoqn","news_summary":"Jamal can see again, thanks to new synthetic cornea","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d1aa07ae-ffb7-4c0d-98fa-3ef8de192af5","date":"Jan 12, 2021","link":"https://www.israelhayom.com/2021/01/12/blind-man-sees-again-thanks-to-israeli-startups-artificial-cornea/","source":"www.israelhayom.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"PQqdEYQPIsv5V6rYfzWx9PmN5moaMaDUIBJsZSrz0UEq7KyRdebJVh","news_summary":"https://www.israelhayom.com/2021/01/12/blind-man-sees-again-thanks-to-israeli-startups-artificial-cornea/","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"198e0b8b-4f9e-4ca1-84c4-580c3fcb1032","date":"Jan 11, 2021","link":"https://www.prnewswire.com/il/news-releases/corneat-vision-s-first-patient-regains-sight-following-artificial-cornea-implantation-at-rabin-medical-center-ending-a-decade-of-blindness-866070880.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Medical Innovation","company":"CorNeat Vision","layoffs":"N/A","summary":"CorNeat Vision, an Israel-based biomimetic implant technology company, has successfully implanted its artificial cornea, CorNeat KPro, in a human for the first time. The surgery was performed on a 78-year-old male at Rabin Medical Center, Israel. The CorNeat KPro, which integrates with the eye wall without relying on donor tissue, immediately enabled the patient to read text and recognize family members after the bandages were removed. The company is planning a multi-national clinical trial to attain CE Mark, FDA Clearance and China NMPA approval.","partners":"Rabin Medical Center","customers":"78-year-old male patient","investors":"N/A","confidence":9,"key_topics":["Artificial Cornea","Clinical Trial","Medical Innovation","Surgery","Visual Impairment"],"date_of_event":"Jan. 11, 2021","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Customers","Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9GgdNCVkS3fVp444opFsSW3EQFW7QtSu6394stSYy1vXxQzRgwvYmO","news_summary":"CorNeat Vision's First Patient Regains Sight Following Artificial Cornea Implantation at Rabin Medical Center, Ending a Decade of Blindness","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"99684872-5c8e-4a02-a558-b532ceb44cfe","date":"Jul 20, 2020","link":"https://www.israel21c.org/first-in-human-trial-of-synthetic-cornea-starts-in-israel/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"Medical Innovation","company":"CorNeat Vision","layoffs":"N/A","summary":"CorNeat Visions first-in-human implantation of the CorNeat KPro synthetic cornea has been approved for 10 corneally blind patients at Beilinson Hospital in Petah Tikva. The implant is designed to replace deformed, scarred or opacified corneas and is expected to fully rehabilitate the vision of corneally blind patients immediately following implantation. The clinical trial at Beilinson will be led by Dr. Irit Bahar, chief of ophthalmology. Additional trial sites are planned to open later this year in eight hospitals in Canada, the United States, France, China and the Netherlands.","partners":"Beilinson Hospital","customers":"10 corneally blind patients at Beilinson Hospital","investors":"N/A","confidence":9,"key_topics":["CorNeat KPro","Synthetic cornea","Clinical trial","Corneal blindness","Implantation procedure"],"date_of_event":"N/A","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":["Customers","Expand"],"acquisition_amount":"N/A","structuredIssuesShow":"#Customers  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"WEfkEPEUmzFrpL45gDr1OoecqYuZpk2HG7ccQTsJtGTbDh4hcpIN2N","news_summary":"First in-human trial of synthetic cornea starts in Israel","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"935f3580-b908-40b5-bcb2-01430223ed37","date":"Jul 14, 2020","link":"https://www.prnewswire.com/news-releases/corneat-visions-synthetic-cornea-approved-for-first-in-human-implantation-301093020.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Healthcare, Medical Device","company":"CorNeat Vision","layoffs":"N/A","summary":"CorNeat Visions synthetic cornea, CorNeat KPro, has received approval to begin a clinical trial at Beilinson Hospital in Israel. The trial will include 10 corneally blind patients who are not candidates for, or have failed one or more corneal transplantations. The device is designed to replace deformed, scarred or opacified corneas and is expected to fully rehabilitate the vision of corneally blind patients immediately following implantation. Additional sites are planned to open later this year in eight leading hospitals in Canada, the United States, France, China and the Netherlands.","partners":"Beilinson Hospital","customers":"Corneally blind patients","investors":"N/A","confidence":9,"key_topics":"Clinical Trial, Synthetic Cornea, Corneal Transplantation, CorNeat KPro, Medical Innovation","date_of_event":"July 14, 2020","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"DWHntOJIE8QFHw4knXUMhVzCBjDYO0WtbERnVHUpUr4SRY1W7ENFih","news_summary":"CorNeat Vision's Synthetic Cornea Approved for First-in-Human Implantation","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"28311c4a-9a2b-4280-a0f1-fe66a414c855","date":"Jan 10, 2020","link":"https://www.labiotech.eu/biotech-of-the-week/corneat-vision-cornea-transplant/","source":"www.labiotech.eu","visible":1,"analysis":{"tags":"Healthcare, Innovation","company":"CorNeat Vision","layoffs":"Not mentioned","summary":"Israel-based CorNeat Vision is developing an easily-implantable and affordable artificial cornea that could replace donor corneas in people needing transplants. The companys mission is to address the shortage of donor tissue by developing a cornea made from plastic that is easier to supply and implant than donor corneas. The implant is designed to integrate with eye tissue better than existing synthetic corneas. CorNeat raised a seed round of €1.4M ($1.5M) in 2016 and in 2018, it raised another €6.5M ($7.2M). The company is now applying for clearance to enter phase I trials in humans and hopes to get market approval for the synthetic cornea in 2021.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not specified","confidence":8,"key_topics":["Artificial Cornea","Transplants","Clinical Trials","Funding","Blindness"],"date_of_event":"Not specified","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"$8.7M","structured_issues":["Investment","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"jXRu9vqJQ5M8xYnMpZ3ySp0FN9YKTT6IUDlSZRg8XBHzduYSZ6yqab","news_summary":"This Biotech Makes Easily Implantable Artificial Cornea Transplants","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a24171c3-f4a6-4c55-9161-6c8ca07ea4b1","date":"Sep 9, 2019","link":"https://www.prnewswire.com/news-releases/corneat-vision-completes-pre-clinical-phase-for-synthetic-cornea-and-scleral-patch-300913973.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"medical technology, ophthalmic solutions","company":"CorNeat Vision","layoffs":"N/A","summary":"Israeli ophthalmic medical solution company, CorNeat Vision, has completed the pre-clinical stage of its cornea implant and the first synthetic, non-degradable scleral patch. The companys solutions, which also include a glaucoma drainage device, will be showcased at the 37th Congress of the ESCRS in Paris, France. CorNeats synthetic biology technology enables its ophthalmic implants to integrate with surrounding tissue. The companys pre-clinical trials proved the safety of its technology as it applied to its synthetic cornea, synthetic scleral patch and glaucoma shunt.","partners":"ESCRS (European Society of Cataract and Refractive Surgeons)","customers":"N/A","investors":"N/A","confidence":9,"key_topics":"Cornea Implant, Scleral Patch, Glaucoma Drainage Device, Pre-Clinical Trials, ESCRS Congress","date_of_event":"Sept. 9, 2019","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Customers, Partners","acquisition_amount":"N/A","structuredIssuesShow":"#Customers, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"qjK0n9U97uLgkpIeCOsihS1VkVZSPSvMZm1mbqzgUWHxPy3tPKmKPh","news_summary":"CorNeat Vision Completes Pre-clinical Phase For Synthetic Cornea and Scleral Patch","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c7233af0-fc43-442d-86e9-411c5bd58fe9","date":"May 21, 2019","link":"https://www.jpost.com/Jpost-Tech/Business-and-Innovation/Spotlight-on-Israeli-startups-Corneat-Vision-artificial-cornea-589759","source":"www.jpost.com","visible":1,"analysis":{"tags":"Medical Devices","company":"Corneat Vision","layoffs":"N/A","summary":"Corneat Vision, an Israeli company, is developing an artificial cornea to help people suffering from corneal blindness regain their eyesight. The company is currently concluding the pre-clinical phase and plans to enter the clinical phase in June 2019. Two clinical studies are planned in Israel, Canada, the US, France, and China. The companys first device, a tissue substitute for ophthalmic surgeries, is expected to hit the market in late 2020, with the artificial cornea following in mid-2021.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Artificial cornea","Clinical studies","Ophthalmic surgeries","Medical Devices","Market launch"],"date_of_event":"May 21, 2019","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"qexGWJslPk3YKbyVRseHq5GnbGMoUh29u8K26yzhqgqBzJM8sPKiiL","news_summary":"https://www.jpost.com/Jpost-Tech/Business-and-Innovation/Spotlight-on-Israeli-startups-Corneat-Vision-artificial-cornea-589759","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4a769fcb-3b23-4cfa-b319-1ce73de78efa","date":"Oct 8, 2017","link":"http://www.globes.co.il/en/article-israeli-co-corneat-vision-unveils-artificial-cornea-1001207325","source":"www.globes.co.il","visible":1,"analysis":{"tags":"Medical Technology","company":"CorNeat Vision","layoffs":"N/A","summary":"Israeli ophthalmic medical devices startup CorNeat Vision has completed the design and development stage of its artificial cornea implant, CorNeat KPro. The company has successfully trialled the implant in rabbits and is now moving towards biocompatibility and safety tests for human implantation by mid-2018. The CorNeat KPro implant uses advanced cell technology to integrate artificial optics within resident ocular tissue. The companys CEO, Almog Aley-Raz, stated that the implant could provide a remedy for the 20-30 million patients worldwide in need of a solution for corneal pathology.","partners":"N/A","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Artificial Cornea Implant","Medical Trials","Ophthalmic Devices","Cell Technology","Corneal Blindness"],"date_of_event":"October 8, 2017","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"N/A","structured_issues":"Investment, Expand","acquisition_amount":"N/A","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"hX8SzM0Ke3aQ50fixxwCKdE1KwUjroSPja5beUvieid6uaDfshAm9H","news_summary":"Israeli co CorNeat Vision unveils artificial cornea","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":13,"techcommunityinvolvement":null,"mediagallery":[{"id":"70fe441b-0352-43d8-b454-fbbeddaed6d6","timestamp":"2022-07-17 08:15:58.000000","resources_type":2,"resources_title":"CorNeat KPro implantation - France (part 2)","resources_file_name":"pRPxJyqCcwY","alt":"CorNeat KPro implantation - France (part 2) logo","imageurl":"https://img.youtube.com/vi/pRPxJyqCcwY/0.jpg","url":"http://youtu.be/pRPxJyqCcwY"},{"id":"8ef89f3a-db8a-48a4-bf96-021f072ba7ae","timestamp":"2022-07-17 08:15:23.000000","resources_type":2,"resources_title":"CorNeat KPro implantation - France","resources_file_name":"-l9n8MssOgk","alt":"CorNeat KPro implantation - France logo","imageurl":"https://img.youtube.com/vi/-l9n8MssOgk/0.jpg","url":"http://youtu.be/-l9n8MssOgk"},{"id":"1cf8310c-512f-4a42-b0b4-7d94777b35aa","timestamp":"2021-02-02 13:12:11.000000","resources_type":2,"resources_title":"CorNeat Vision Primetime News","resources_file_name":"lOtu1nZBZl0","alt":"CorNeat Vision Primetime News logo","imageurl":"https://img.youtube.com/vi/lOtu1nZBZl0/0.jpg","url":"http://youtu.be/lOtu1nZBZl0"},{"id":"78e15c12-81b8-4ac2-bb0f-96a35d575e47","timestamp":"2020-07-19 07:27:23.000000","resources_type":2,"resources_title":"CorNeat KPro Animation","resources_file_name":"-sNW3F933v8","alt":"CorNeat KPro Animation logo","imageurl":"https://img.youtube.com/vi/-sNW3F933v8/0.jpg","url":"http://youtu.be/-sNW3F933v8"}],"tags":["healthcare","medical-devices","visually-impaired","eye-diseases"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Released","products":["CorNeat gPatch","CorNeat eShunt","CorNeat KPro","CorNeat EverPatch"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$2.5M","totalrounds":7,"fundingstage":"B","totalfunding":"$18.77M","publicinvestors":2,"lastpublicfunding":2500000,"totalpublicrounds":7,"totalpublicfunding":18765000},"team":[{"name":"Gilad Litvin","email":"gilad@corneat.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJzuis4KDA","bounced":false,"claimed":1,"founder":1,"urlname":"gilad-litvin-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg1NOSkAoM","position":"Co-founder, Chairman, Chief Medical Officer","last_name":"Litvin","claimtoken":"4828c5b4f363fefc6015edb923cccc6a420d9ffd1a01c3de8fab648f35505845","first_name":"Gilad","picturekey":"$mr0ONCI6NTYG087kpVgv3NVSDhIxlfzsEOh8B9AI5J8c0vFvK2EUGA","claimeddate":"2020-08-24","linkedinurl":"https://www.linkedin.com/in/gilad-litvin-06b18386","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-08-24 08:28:15.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$mr0ONCI6NTYG087kpVgv3NVSDhIxlfzsEOh8B9AI5J8c0vFvK2EUGA","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Almog Aley-raz","email":"almog@corneat.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4LG_8awIDA","bounced":false,"claimed":1,"founder":1,"urlname":"almog-aley-raz","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgsb_xzAkM","position":"Co-founder & CEO & VP R&D","last_name":"Aley-raz","claimtoken":"6524a2eb21c78fdbf4eb5b8057b9977fbe064afedbf0018be6b44bf69980cf4b","first_name":"Almog","picturekey":"$zMo00DWZZsFkvJdLvNLCKTRqqmo1WbtEoh7P6EFL2F4A8hVoN4R4sU","claimeddate":"2020-08-24","linkedinurl":"https://www.linkedin.com/in/almog-aley-raz-87559a/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-08-24 08:20:40.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$zMo00DWZZsFkvJdLvNLCKTRqqmo1WbtEoh7P6EFL2F4A8hVoN4R4sU","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Gil Lotan","email":"gil@corneat.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4NG9z54JDA","bounced":false,"claimed":1,"founder":0,"urlname":"gil-lotan","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgsbbc-gsM","position":"VP Business Development","last_name":"Lotan","claimtoken":"cf10d8e55155f2ea31a6d26af658180cd3fd0df8090e5baa078e57abdc4da274","first_name":"Gil","picturekey":"$kx0x3BztCi4Uccfc9wR5n0MpEc4feDaIORCQEhkRoqd3WylpngwBCp","claimeddate":"2020-07-30","linkedinurl":"https://www.linkedin.com/in/gil-lotan-13815b/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-07-30 07:21:55.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$kx0x3BztCi4Uccfc9wR5n0MpEc4feDaIORCQEhkRoqd3WylpngwBCp","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Sapir Buchris","email":"sapir@corneat.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4PGXgcsIDA","bounced":false,"claimed":1,"founder":0,"urlname":"sapir-buchris","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgycSh3ggM","position":"VP Operations and Corporate Development","last_name":"Buchris","claimtoken":"a55648d8240eb7811f5b761fa5be23a982a655c370f8ae5655018b2c6bc9f11f","first_name":"Sapir","picturekey":"$ePfO28SEjomaYc116FG61JdxLEE0oUOMy09EdfBQELz0B1Ucgt5lHI","claimeddate":"2020-07-29","linkedinurl":"https://www.linkedin.com/in/sapir-buchris-251b80145/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-07-29 07:10:57.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$ePfO28SEjomaYc116FG61JdxLEE0oUOMy09EdfBQELz0B1Ucgt5lHI","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Mai Akunis-Hermann","email":"mai@corneat.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4JbtxrgKDA","bounced":false,"claimed":1,"founder":0,"urlname":"mai-akunis-hermann","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgoZa3oggM","position":"Marketing And Business Development Coordinator","last_name":"Akunis-Hermann","claimtoken":"0465621c725c75b67d1f94170091801e04d31b02bd8911977f5f1efe26900f59","first_name":"Mai","picturekey":"$Dh74DDPgoQoYdnzkPvfXVIhHeJ2skcI082soh6x0psEWDpRsLrQkVr","claimeddate":"2020-07-19","linkedinurl":"https://www.linkedin.com/in/mai-akunis-hermann-192a41b1/","unsubscribed":false,"is_activeuser":1,"additionalemail":"maihermann@gmail.com","claimedemaildate":"2020-07-19 07:02:44.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$Dh74DDPgoQoYdnzkPvfXVIhHeJ2skcI082soh6x0psEWDpRsLrQkVr","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwPi8kYoKDA","fullname":"Ayelet Beazley"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMGgoMMJDA","fullname":"Yanina Wainscheinker"},"biverifydate":"2020-02-19T00:00:00.000Z","crunchbaseid":"corneat-vision","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Jenny Sotnik-Talisman","creator_email":"genys30@yahoo.com","createdate":"2017-10-09T00:00:00.000Z","biverification":"Yanina Wainscheinker","sectorverification":"Ayelet Beazley","affiliatedOrganizations":null,"timeline":[{"id":"iteLIzahdDr15C6iZBUOt0cCWkhq8GR8tGlUhxkDdu1I92BpvXeqPv","hub":"MedTech Innovator","date":"Jun 2022","batch":"","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODEnKiUCQw","source":"https://www.medicaldesignandoutsourcing.com/medtech-innovator-startups-cohort-accelerator-program/","enddate":"Oct 2022","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":true,"investment":[],"hub_fullurl":"/program_page/medtech-innovator-1","hub_logokey":"$TNK8DfLCwwc25SDtbhxJcp6w8yvJg8UGCj0CHlUB2jEjNNZUs2EYLR","hub_urlname":"/program_page/medtech-innovator-1","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$TNK8DfLCwwc25SDtbhxJcp6w8yvJg8UGCj0CHlUB2jEjNNZUs2EYLR","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDi95yZCgw","date":"May 2022","amount":"$2.5M","source":"Added by Mai Akunis-Hermann","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Commission","type":"Company","amount":null,"hidden":true,"country":"Belgium","fullurl":"/company_page/european-commission","logokey":"$E7bRUi5i2O7c40Iisf5CTwRqUu10LyEfJVqIEKIadDQCfpmJCGaaAG","tagline":"","urlname":"/company_page/european-commission","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC4jqaLCAw","fundingtype":"Company","leadpartner":null,"investmentid":"tBZCej29x5ZtyD8ZBpTdsVdAloX98vvz8VgOAOW3goLYe9kCVfnvRd","fundingsubtype":"","investorislead":1,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$E7bRUi5i2O7c40Iisf5CTwRqUu10LyEfJVqIEKIadDQCfpmJCGaaAG","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCg8fqTCgw","date":"Aug 2021","amount":"$4M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3916036,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Guangzhou Sino-Israel Biotech Investment Fund (GIBF)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/guangzhou-sino-israel-biotech-investment-fund-gibf","logokey":"$EhT54op1KN0bFQNfuNUIQuiaUEJvmdfmQuYVDy8ZGOHTKVos9xOEZg","tagline":null,"urlname":"/investor_page/guangzhou-sino-israel-biotech-investment-fund-gibf","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Nf6pOwIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"c41921ae-7373-49f2-b6eb-18017f4ddc89","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$EhT54op1KN0bFQNfuNUIQuiaUEJvmdfmQuYVDy8ZGOHTKVos9xOEZg","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODR4OjjCQw","date":"May 2020","amount":"$3.4M","source":"Added by Chen Pirkes ","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"b03df0a5-e875-4131-83d4-5e82f5348190","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3400000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODR4PyCCww","date":"Dec 2018","amount":"$7.2M","source":"Added by Mai Akunis-Hermann","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ac4ed55e-83f1-4c97-9e37-551aab38d7f2","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7200000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5ca0CAw","date":"Apr 2018","amount":"$200K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"China (Shenzhen) Innovation & Entrepreneurship International Competition","type":"Other","amount":0,"hidden":false,"country":"China","fullurl":"/company_page/china-shenzhen-innovation-entrepreneurship-international-competition","logokey":"$7ZdeK1PPGyGalRTwzX8GcMyMtVDBtxedbQbX4naLF1cj3Vfm8XfEko","tagline":"","urlname":"/company_page/china-shenzhen-innovation-entrepreneurship-international-competition","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD42feWCQw","fundingtype":"Other","leadpartner":null,"investmentid":"8aa72b4e-bc8d-45ff-9d01-811043c2eb69","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7ZdeK1PPGyGalRTwzX8GcMyMtVDBtxedbQbX4naLF1cj3Vfm8XfEko","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":200000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2q_YCAw","date":"Nov 2017","amount":"$15K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"Xi'an international startup competition","type":"Accelerator","amount":0,"hidden":true,"country":"China","fullurl":"/program_page/xian-international-startup-competition","logokey":"$OR57jbNRqsPPtZ6G6x6MpRMmsKGER9WcSoJ7lfc8fp4LqZEDqUg05J","tagline":"","urlname":"/program_page/xian-international-startup-competition","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqLCjCQw","fundingtype":"General","leadpartner":null,"investmentid":"a26fd40f-9db0-42b2-b9dd-2d599e13b1f1","fundingsubtype":"General","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OR57jbNRqsPPtZ6G6x6MpRMmsKGER9WcSoJ7lfc8fp4LqZEDqUg05J","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":15000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODRoN6FCww","date":"Nov 2017","amount":"$1.45M","source":"Added by Mai Akunis-Hermann","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"737730c8-82d9-4c86-af8c-35608b0cb38e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1450000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"12/2015","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"CorNeat Vision","logourl":"https://storage.googleapis.com/clean-finder-353810/$QWmqvmWtjlXJI2bOLj0Dwbv4I8DSwA4y8bsd1g408JmVcyd0XIxoR1","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$QWmqvmWtjlXJI2bOLj0Dwbv4I8DSwA4y8bsd1g408JmVcyd0XIxoR1","seoabout":"CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, Cor...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":5,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA>Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|2:>TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA/Implants#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Biomaterials & Tissue Engineering","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Biomaterials & Tissue Engineering"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"}]}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances","children":[{"title":"Implants","key":"0-0-0","path":"TechnologyClassificationModel>Materials & Substances>Implants"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":2,"name":"Implants","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeKhcYLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Biomaterials & Tissue Engineering"],"coreTechnology":["Materials & Substances","Implants"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCg8fqTCgw","date":"Aug 2021","amount":"$4M","source":"https://www.calcalistech.com/ctech/articles/0,7340,L-3916036,00.html","eventtype":"FundingRoundEvent","investment":[{"name":"Guangzhou Sino-Israel Biotech Investment Fund (GIBF)","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/guangzhou-sino-israel-biotech-investment-fund-gibf","logokey":"$EhT54op1KN0bFQNfuNUIQuiaUEJvmdfmQuYVDy8ZGOHTKVos9xOEZg","tagline":null,"urlname":"/investor_page/guangzhou-sino-israel-biotech-investment-fund-gibf","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Nf6pOwIDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"c41921ae-7373-49f2-b6eb-18017f4ddc89","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$EhT54op1KN0bFQNfuNUIQuiaUEJvmdfmQuYVDy8ZGOHTKVos9xOEZg","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Undisclosed Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODR4OjjCQw","date":"May 2020","amount":"$3.4M","source":"Added by Chen Pirkes ","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"b03df0a5-e875-4131-83d4-5e82f5348190","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"B Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":3400000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODR4PyCCww","date":"Dec 2018","amount":"$7.2M","source":"Added by Mai Akunis-Hermann","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ac4ed55e-83f1-4c97-9e37-551aab38d7f2","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":7200000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODRoN6FCww","date":"Nov 2017","amount":"$1.45M","source":"Added by Mai Akunis-Hermann","eventtype":"FundingRoundEvent","investment":[{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":false,"country":"Europe","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"737730c8-82d9-4c86-af8c-35608b0cb38e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1450000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDi95yZCgw","date":"May 2022","amount":"$2.5M","source":"Added by Mai Akunis-Hermann","eventtype":"GrantEvent","granttype":1,"investment":[{"name":"European Commission","type":"Company","amount":null,"hidden":true,"country":"Belgium","fullurl":"/company_page/european-commission","logokey":"$E7bRUi5i2O7c40Iisf5CTwRqUu10LyEfJVqIEKIadDQCfpmJCGaaAG","tagline":"","urlname":"/company_page/european-commission","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC4jqaLCAw","fundingtype":"Company","leadpartner":null,"investmentid":"tBZCej29x5ZtyD8ZBpTdsVdAloX98vvz8VgOAOW3goLYe9kCVfnvRd","fundingsubtype":"","investorislead":1,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$E7bRUi5i2O7c40Iisf5CTwRqUu10LyEfJVqIEKIadDQCfpmJCGaaAG","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5ca0CAw","date":"Apr 2018","amount":"$200K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"China (Shenzhen) Innovation & Entrepreneurship International Competition","type":"Other","amount":0,"hidden":false,"country":"China","fullurl":"/company_page/china-shenzhen-innovation-entrepreneurship-international-competition","logokey":"$7ZdeK1PPGyGalRTwzX8GcMyMtVDBtxedbQbX4naLF1cj3Vfm8XfEko","tagline":"","urlname":"/company_page/china-shenzhen-innovation-entrepreneurship-international-competition","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD42feWCQw","fundingtype":"Other","leadpartner":null,"investmentid":"8aa72b4e-bc8d-45ff-9d01-811043c2eb69","fundingsubtype":"","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$7ZdeK1PPGyGalRTwzX8GcMyMtVDBtxedbQbX4naLF1cj3Vfm8XfEko","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":200000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk2q_YCAw","date":"Nov 2017","amount":"$15K","source":"Added by Daniela Gehtaman","eventtype":"GrantEvent","granttype":0,"investment":[{"name":"Xi'an international startup competition","type":"Accelerator","amount":0,"hidden":true,"country":"China","fullurl":"/program_page/xian-international-startup-competition","logokey":"$OR57jbNRqsPPtZ6G6x6MpRMmsKGER9WcSoJ7lfc8fp4LqZEDqUg05J","tagline":"","urlname":"/program_page/xian-international-startup-competition","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEqLCjCQw","fundingtype":"General","leadpartner":null,"investmentid":"a26fd40f-9db0-42b2-b9dd-2d599e13b1f1","fundingsubtype":"General","investorislead":null,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OR57jbNRqsPPtZ6G6x6MpRMmsKGER9WcSoJ7lfc8fp4LqZEDqUg05J","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":15000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}